NeuroScientific Biopharmaceuticals has dosed a fourth Crohn’s disease patient with its StemSmart stem-cell therapy, in a step ...
There's one main way to treat inflammatory bowel disease (IBD): Control inflammation by whipping the immune system into shape, a process that can go haywire or fail to work. But what if the body could ...
Neuroscientific Biopharmaceuticals Ltd. ( ($AU:NSB) ) has issued an announcement. NeuroScientific Biopharmaceuticals has initiated treatment for ...
Phase II study to evaluate the potential of HB-adMSCs in reducing inflammation and improving quality of life for adults living with Crohn’s Disease Hope Biosciences Research Foundation (HBRF) today ...
Stem cells can fight disease from the inside out. But not all treatments are created equal. By Mohana Ravindranath The promise of stem cell therapy is powerful. Scientists can draw versatile cells ...
PHILADELPHIA, Oct. 21, 2025 /PRNewswire/ -- In a new study led by researchers at Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania (Penn ...
PHOENIX -- An implantable autologous cell therapy led to higher ... regenerative approach to treating Crohn's perianal ...
UC San Diego researchers combined artificial intelligence with molecular biology to unravel how immune cells in the gut ...
Hope Biosciences Research Foundation (HBRF) today announced the opening of enrollment for a Phase II clinical trial evaluating the potential of intravenously infused allogeneic, adipose-derived ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback